← All trials
NCT04983810
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 12, 2021
- Primary completion
- Oct 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Jul 30, 2021
- Last posted
- Jul 30, 2021
- Enrollment
- 330
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cyclacel Pharmaceuticals, Inc.Lead sponsor
- Cyclacel Pharmaceuticals, Inc.Study chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.